Genetic regulation of PCSK9 (proprotein convertase subtilisin/Kexin type 9) plasma levels and its impact on atherosclerotic vascular disease phenotypes. Circ. Genom. Precis. Med., (11)5:e001992, Ovid Technologies (Wolters Kluwer Health), May 2018. [PUMA: association atherosclerosis; genome-wide study]